Marc Van Ranst

Marc Van Ranst (20 June 1965) is a Belgian virologist and epidemiologist at the Katholieke Universiteit Leuven (Leuven, Belgium) and the Rega Institute for Medical Research. On 1 May 2007 he was appointed as Interministerial comissionar by the Belgian federal government to prepare Belgium for an influenza pandemic. He is affectionately known as "Dr Paljas" by his students.

Education

Born in Bornem, Van Ranst obtained a BA in medicine at Hasselt University (then L.U.C.) in 1986 and later graduated as a medical doctor at the Katholieke Universiteit Leuven in 1990. He specialized in Laboratory Medicine (1998) and obtained a PhD at the K.U. Leuven.

In recent years, he has extensively studied down syndrome which is very prevalent in his family

Career

He started working at the University Hospitals Leuven in 1998 and became Professor of Virology at the K.U. Leuven. Currently, he is associate chief of the department of laboratory medicine, and heads the diagnostic virology laboratory at the University Hospitals Leuven, Belgium. He is also the director of the AIDS reference laboratory and of the national coronavirus and rotavirus reference laboratories. Professor Van Ranst was appointed in 1999 to the Belgian high council for public health. He published over 220 scientific papers in peer reviewed journals and contributed eight chapters to books on molecular evolution and bioinformatics. In 2004 Marc Van Ranst was granted the European Clinical Virology Heine-Medin award of the European Society for Clinical Virology. In 2005, he received a doctor honoris causa degree at the University of Kalmar in Sweden. Marc Van Ranst is the chairman of the editorial board of VacciNewsNet, a social media platform that provides accurate information on vaccines.

Critics

In August 2014, he was the first person who used the term Gazacaust that created heavy reactions in the Jewish community in Belgium and abroad.[1] [2]

References

Sources

External links

This article is issued from Wikipedia - version of the 9/14/2016. The text is available under the Creative Commons Attribution/Share Alike but additional terms may apply for the media files.